ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Ecliptasaponin A attenuates renal fibrosis by regulating the extracellular matrix of renal tubular cells

Li, Xiaomin; Dong, Wenhui; Yang, Yanlin; Ren, Shijing; Wang, Xiangyu; Zou, Meina; Lu, Wen; Liu, Lerong; Xue, Yaoming*南昌大学; 南方医科大学
In Vitro Cellular and Developmental Biology - Animal2023-10DOI: 10.1007/s11626-023-00803-0
11阅读
引用收藏
分享

摘要

Renal fibrosis is the most common manifestation of end-stage renal disease (ESRD), including diabetic kidney disease (DKD), but there is no effective treatment in renal fibrosis. Natural products are a rich source of clinical drug research and have been used in the clinical research of various diseases. In this study, we searched for traditional Chinese medicine monomers that attenuate fibrosis and assessed their effect on the fibrosis marker connective tissue growth factor (CTGF) in cells which we found ecliptasaponin A. Subsequently, we evaluated the effect of ecliptasaponin A on renal fibrosis in the classic renal fibrosis unilateral ureteral obstruction (UUO) mouse model and found that ecliptasaponin A could reduce the renal collagen fiber deposition and renal extracellular matrix (ECM) protein expression in UUO mice. In vitro, ecliptasaponin A can inhibit ECM protein expression in human kidney-2 (HK-2) cells induced by transforming growth factor-beta1 (TGF beta 1). To further clarify the mechanism of ecliptasaponin A in attenuating renal fibrosis, we performed transcriptome sequencing of HK-2 cells treated with TGF beta 1 and ecliptasaponin A. The functions and pathways were mainly enriched in the extracellular matrix and TGF beta signalling pathway. Matrix metalloproteinase 10 (MMP10) and matrix metalloproteinase 13 (MMP13) are the main differentially expressed genes in extracellular matrix regulation. Then, we measured MMP10 and MMP13 in the cells and found that ecliptasaponin A had a significant inhibitory effect on MMP13 expression but not on MMP10 expression. Furthermore, we overexpressed MMP13 in HK-2 cells treated with TGF beta 1 and found that MMP13 promoted HK-2 cell injury. Our findings suggest that ecliptasaponin A can attenuate renal fibrosis, which may provide a new method for treating renal fibrosis clinically.

学科与关键词

关键词
Renal fibrosisExtracellular matrixEcliptasaponin AMMP13Diabetic kidney disease
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
In Vitro Cellular and Developmental Biology - Animal
发表日期
2023-10
卷期
第 59 卷, 第 9 期
页码
684-696
DOI
10.1007/s11626-023-00803-0
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82070848]; GuangDong Basic and Applied Basic Research Foundation [2021A1515010998]; Key-Area Research and Development Program of Guangdong Province [2019B020230001]; Natural Science Foundation of Guangdong [2021A1515111025]

作者

  • L

    Li, Xiaomin (第一作者)

    southern med univ

  • D

    Dong, Wenhui

    southern med univ

查看全部 9 位作者收起作者
  • Y

    Yang, Yanlin

    southern med univ · 2 · nanchang univ

  • R

    Ren, Shijing

    southern med univ

  • W

    Wang, Xiangyu

    southern med univ

  • Z

    Zou, Meina

    southern med univ

  • L

    Lu, Wen

    southern med univ

  • L

    Liu, Lerong

    southern med univ

  • X

    Xue, Yaoming (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417